BCL2L11 and Parkinson disease: demonstrated SIRT2 exacerbates neuronal apoptosis and nigrostriatal damage by deacetylating Foxo3a and activating Bim both in vitro (36) and in vivo Parkinson’s disease (PD) model (37).